Zydus Lifesciences Buyback 2024 Record Date, Price, Entitlement Ratio

0
Zydus Lifesciences Buyback Record Date

Zydus Lifesciences Buyback Record Date is 23 February 2024.

The company was initially incorporated as Cadila Healthcare Private Limited on 15 May 1995, under the provisions of the Companies Act, 1956. It later converted to a public limited company and changed its name to Cadila Healthcare Limited on 17 July 1996. Subsequently, on 24 February 2022, the company changed its name to its present name, ‘Zydus Lifesciences Limited’.

Zydus Lifesciences is a prominent innovation-driven life sciences company in India. It operates across the pharmaceutical value chain, engaging in research and development, manufacturing, marketing, and selling of finished dosage human formulations. These include generics, branded generics, and specialty formulations, encompassing biosimilars and vaccines.

The company operates 35 manufacturing facilities, plants, and factories in India. Additionally, it maintains 7 research and development centers in the country, focusing on generic formulations, active pharmaceutical ingredients (API), vaccines, biologics, and new chemical entities across various dosage forms.

Zydus Lifesciences Buyback 2024

Zydus Lifesciences Buyback Record Date, Other Details

Zydus Lifesciences Buyback DatesComing soon
Zydus Lifesciences Buyback Price INR 1,005 per share
Market Price on Buyback ApprovalINR 801.85 per share
Buyback Premium on Market Price25.34%
Buyback Offer Size (Shares)5,970,149 shares
Buyback Offer Size (Amount)INR 600 crore
Offer TypeTender
Promoter ParticipationYes
Face Value INR 1 per share
Listing AtBSE, NSE

Zydus Lifesciences Buyback Dates (Timeline)

Board Meeting Intimation for Buyback Proposal29 January 2024
Buyback Approval Date9 February 2024
Public Announcement of Buyback13 February 2024
Zydus Lifesciences Buyback Record Date23 February 2024
Buyback Opening DateComing soon
Buyback Closing DateComing soon
Cut-off Date to receive completed tender forms by RegistrarComing soon
Verification Date by the RegistrarComing soon
Return of unaccepted shares by RegistrarComing soon
Extinguishment of accepted sharesComing soon

Zydus Lifesciences Buyback 2024 Documents

Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback


Zydus Lifesciences Buyback Entitlement Ratio

Shareholder CategoryEntitlement RatioEntitlement Ratio (in %)
Small Shareholders
(less than INR 2 Lakh on record date)
5.30*
General category
(for all other Eligible Shareholders)
*Calculated by IPO Central

A small Shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.


Zydus Lifesciences Financial Performance

FY 2021FY 2022FY 2023
Revenue14,403.515,109.917,237.4
Total Expenses11,844.812,609.214,230.1
Net income 2,185.04,618.32,091.9
Figures in INR Crores unless specified otherwise

Calculation of Investment in Buyback

Maximum market value of a share holder as on record dateINR 2,00,000
Buyback price per shareINR 1,005
Maximum shares for small shareholders (2,00,000/1,005)200 shares *
Closing price of stock as of 9 February 2024INR 801.85**
Maximum amount invested in buyback (INR 801.85 x 200 shares)INR 1,60,385
* No. of shares stands to change according to the closing price on the record date
** For simplicity, we have considered the price on the buyback approval date

Zydus Lifesciences Buyback Acceptance Ratio

Shares Tendered Buyback EntitlementAcceptance ratioBuyback ProfitProfit in %
2001111 (100%)2,234.651.39
2001122 (200%)4,469.302.79
2001133 (300%)6,703.954.18

Registrar of Zydus Lifesciences Buyback 2024

LINK INTIME INDIA PRIVATE LIMITED
C-101, 247 Park, 1st Floor, L.B.S. Marg,
Vikhroli West, Mumbai, 400 083, Maharashtra
Phone: +91 22 49186200
Email: [email protected]
Website: www.linkintime.com


Manager of Zydus Lifesciences Buyback 2024

ICICI SECURITIES LIMITED
ICICI Venture House, Appasaheb Marathe Marg,
Prabhadevi, Mumbai – 400 025, Maharashtra
Phone: +91 22 6807 7100
Email: [email protected] / [email protected]
Website: www.icicisecurities.com


Process to Participate in Zydus Lifesciences Buyback

All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.

The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.

The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.


Frequently Asked Questions

What are Zydus Lifesciences’ buyback dates?

Zydus Lifesciences’ share buyback opens in 2024 and closes in 2024.

Which type of buyback is Zydus Lifesciences buyback offer?

Zydus Lifesciences buyback is a tender offer.

What is Zydus Lifesciences buyback price?

Zydus Lifesciences buyback price is INR 1,005 per share.

What is Zydus Lifesciences buyback record date?

Zydus Lifesciences buyback record date is 23 February 2024.

How to participate in Zydus Lifesciences share buyback?

Zydus Lifesciences share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.

LEAVE A REPLY

Please enter your comment!
Please enter your name here